Splicing factor transformer-2b (Tra2b) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Li, Shu Jing ^a   Li, Ya ^a   Cui, Shi Chao ^a   Qi, Yao ^a   Zhao, Jing Jing ^a   Liu, Xiao Yan ^a   Xu, Ping ^a   Chen, Xian Hua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ASF; REGULATOR PROTEIN; RGS4 PROTEIN; SERINE ARGININE RICH PROTEIN; TRANSFORMER 2BETA PROTEIN; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; MORPHINE; NERVE PROTEIN; RGS PROTEIN; RNA BINDING PROTEIN; TRA2B PROTEIN, RAT;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; EXON; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LOCUS CERULEUS; MALE; MORPHINE ADDICTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RGS4 1 GENE; RGS4 GENE; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; BRAIN; BRAIN MAPPING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPORTER GENE; SPRAGUE DAWLEY RAT;

RATTUS;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; BRAIN MAPPING; EXONS; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; MALE; MORPHINE; MORPHINE DEPENDENCE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RGS PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84922482114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072220     Document Type: Article

References (76)

1. Hooks SB, Martemyanov K, Zachariou V (2008) A role of RGS proteins in drug addiction. Biochem Pharmacol 75: 76-84.
2. Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ (1996) RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383: 172-175.
3. Berman DM, Wilkie TM, Gilman AG (1996) GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86: 445-452.
4. Hepler JR, Berman DM, Gilman AG, Kozasa T (1997) RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. Proc Natl Acad Sci U S A 94: 428-432.
5. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001) Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6: 293-301.
6. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, et al. (2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11: 1373-1380.
7. Erdely HA, Tamminga CA, Roberts RC, Vogel MW (2006) Regional alterations in RGS4 protein in schizophrenia. Synapse 59: 472-479.
8. Lerner TN, Kreitzer AC (2012) RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron 73: 347-359.
9. Paspalas CD, Selemon LD, Arnsten AF (2009) Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb Cortex 19: 2145-2155.
10. Gold SJ, Ni YG, Dohlman HG, Nestler EJ (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci 17: 8024-8037.
11. Erdely HA, Lahti RA, Lopez MB, Myers CS, Roberts RC, et al. (2004) Regional expression of RGS4 mRNA in human brain. Eur J Neurosci 19: 3125-3128.
12. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, et al. (2004) Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res Mol Brain Res 122: 24-34.
13. Leontiadis LJ, Papakonstantinou MP, Georgoussi Z (2009) Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu-and delta-opioid receptor signaling. Cell Signal 21: 1218-1228.
14. Wang Q, Liu-Chen LY, Traynor JR (2009) Differential modulation of mu-and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells. J Biol Chem 284: 18357-18367.
15. Talbot JN, Roman DL, Clark MJ, Roof RA, Tesmer JJ, et al. (2010) Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent. J Neurochem 112: 1026-1034.
16. Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, et al. (2010) Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol Psychiatry 67: 761-769.
17. Krumins AM, Barker SA, Huang C, Sunahara RK, Yu K, et al. (2004) Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem 279: 2593-2599.
18. Ni YG, Gold SJ, Iredale PA, Terwilliger RZ, Duman RS, et al. (1999) Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci 19: 3674-3680.
19. Gold SJ, Han MH, Herman AE, Ni YG, Pudiak CM, et al. (2003) Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 17: 971-980.
20. Bishop GB, Cullinan WE, Curran E, Gutstein HB (2002) Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol Dis 10: 334-343.
21. Schwendt M, Gold SJ, McGinty JF (2006) Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles of D1 and D2 dopamine receptors. J Neurochem 96: 1606-1615.
22. Rivero G, Gabilondo AM, Garcia-Fuster MJ, La Harpe R, Garcia-Sevilla JA, et al. (2012) Differential regulation of RGS proteins in the prefrontal cortex of short-and long-term human opiate abusers. Neuropharmacology 62: 1044-1051.
23. Ding L, Mychaleckyj JC, Hegde AN (2007) Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain. Gene 401: 46-60.
24. Emilsson L, Saetre P, Jazin E (2006) Low mRNA levels of RGS4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression. Synapse 59: 173-176.
25. Muma NA, Mariyappa R, Williams K, Lee JM (2003) Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Synapse 47: 58-65.
26. Grillet N, Dubreuil V, Dufour HD, Brunet JF (2003) Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b. J Neurosci 23: 10613-10621.
27. Maniatis T, Tasic B (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418: 236-243.
28. Fu XD (1995) The superfamily of arginine/serine-rich splicing factors. RNA 1: 663-680.
29. Manley JL, Tacke R (1996) SR proteins and splicing control. Genes Dev 10: 1569-1579.
30. Graveley BR, Maniatis T (1998) Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell 1: 765-771.
31. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, et al. (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci U S A 100: 13656-13661.
32. D'Souza I, Schellenberg GD (2006) Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K. J Biol Chem 281: 2460-2469.
33. Young PJ, DiDonato CJ, Hu D, Kothary R, Androphy EJ, et al. (2002) SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. Hum Mol Genet 11: 577-587.
34. Xie GX, Palmer PP (2005) RGS proteins: new players in the field of opioid signaling and tolerance mechanisms. Anesth Analg 100: 1034-1042.
35. Davydov IV, Varshavsky A (2000) RGS4 is arginylated and degraded by the N-end rule pathway in vitro. J Biol Chem 275: 22931-22941.
36. Chen X, Guo L, Lin W, Xu P (2003) Expression of Tra2beta isoforms is developmentally regulated in a tissue-and temporal-specific pattern. Cell Biol Int 27: 491-496.
37. Jiang Z, Tang H, Havlioglu N, Zhang X, Stamm S, et al. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J Biol Chem 278: 18997-19007.
38. Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, et al. (2006) The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem 96: 635-644.
39. Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B (2000) Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A 97: 9618-9623.
40. Chen X, Huang J, Li J, Han Y, Wu K, et al. (2004) Tra2betal regulates P19 neuronal differentiation and the splicing of FGF-2R and GluR-B minigenes. Cell Biol Int 28: 791-799.
41. Matsuo N, Ogawa S, Imai Y, Takagi T, Tohyama M, et al. (1995) Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/reoxygenation. J Biol Chem 270: 28216-28222.
42. Kiryu-Seo S, Matsuo N, Wanaka A, Ogawa S, Tohyama M, et al. (1998) A sequence-specific splicing activator, tra2beta, is up-regulated in response to nerve injury. Brain Res Mol Brain Res 62: 220-223.
43. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144.
44. Grabowski PJ, Black DL (2001) Alternative RNA splicing in the nervous system. Prog Neurobiol 65: 289-308.
45. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17: 419-437.
46. Caceres JF, Screaton GR, Krainer AR (1998) A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12: 55-66.
47. Lemaire R, Prasad J, Kashima T, Gustafson J, Manley JL, et al. (2002) Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins. Genes Dev 16: 594-607.
48. Huang Y, Gattoni R, Stevenin J, Steitz JA (2003) SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol Cell 11: 837-843.
49. Sanford JR, Gray NK, Beckmann K, Caceres JF (2004) A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18: 755-768.
50. Li SJ, Qi Y, Zhao JJ, Li Y, Liu XY, et al. (2013) Characterization of nuclear localization signals (NLSs) and function of NLSs and phosphorylation of serine residues in subcellular and subnuclear localization of transformer-2beta (Tra2beta). J Biol Chem 288: 8898-8909.
51. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, et al. (1997) CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17: 7890-7901.
52. Law PY, Wong YH, Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389-430.
53. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophys-iological, and biochemical correlates. J Neurosci 10: 2308-2317.
54. Benderska N, Becker K, Girault JA, Becker CM, Andreadis A, et al. (2010) DARPP-32 binds to tra2-beta1 and influences alternative splicing. Biochim Biophys Acta 1799: 448-453.
55. Stipanovich A, Valjent E, Matamales M, Nishi A, Ahn JH, et al. (2008) A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature 453: 879-884.
56. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
57. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21: 467-476.
58. Helmstetter FJ, Tershner SA (1994) Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J Neurosci 14: 7099-7108.
59. Guimaraes AP, Prado WA (1994) Antinociceptive effects of carbachol microinjected into different portions of the mesencephalic periaqueductal gray matter of the rat. Brain Res 647: 220-230.
60. Pan YX (2005) Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 24: 736-750.
61. Gris P, Gauthier J, Cheng P, Gibson DG, Gris D, et al. (2010) A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism. Mol Pain 6: 33.
62. Chatterjee TK, Liu Z, Fisher RA (2003) Human RGS6 gene structure, complex alternative splicing, and role of N terminus and G protein gamma-subunit-like (GGL) domain in subcellular localization of RGS6 splice variants. J Biol Chem 278: 30261-30271.
63. Tosetti P, Parente V, Taglietti V, Dunlap K, Toselli M (2003) Chick RGS2L demonstrates concentration-dependent selectivity for pertussis toxin-sensitive and-insensitive pathways that inhibit L-type Ca2+ channels. J Physiol 549: 157-169.
64. Chatterjee TK, Eapen AK, Fisher RA (1997) A truncated form of RGS3 negatively regulates G protein-coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C. J Biol Chem 272: 15481-15487.
65. Liang Y, Li C, Guzman VM, Chang WW, Evinger AJ,. (2005) Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues. FEBS J 272: 791-799.
66. Itoh M, Nagatomo K, Kubo Y, Saitoh O (2006) Alternative splicing of RGS8 gene changes the binding property to the M1 muscarinic receptor to confer receptor type-specific Gq regulation. J Neurochem 99: 1505-1516.
67. Granneman JG, Zhai Y, Zhu Z, Bannon MJ, Burchett SA, et al. (1998) Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. Mol Pharmacol 54: 687-694.
68. Rahman Z, Gold SJ, Potenza MN, Cowan CW, Ni YG, et al. (1999) Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci 19: 2016-2026.
69. Chatterjee TK, Fisher RA (2000) Novel alternative splicing and nuclear localization of human RGS12 gene products. J Biol Chem 275: 29660-29671.
70. Xie GX, Yanagisawa Y, Ito E, Maruyama K, Han X, et al. (2005) N-terminally truncated variant of the mouse GAIP/RGS19 lacks selectivity of full-length GAIP/RGS19 protein in regulating ORL1 receptor signaling. J Mol Biol 353: 1081-1092.
71. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, et al. (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762.
72. Saito M, Ehringer MA, Toth R, Oros M, Szakall I, et al. (2003) Variants of kappa-opioid receptor gene and mRNA in alcohol-preferring and alcohol-avoiding mice. Alcohol 29: 39-49.
73. Tolle TR, Herdegen T, Schadrack J, Bravo R, Zimmermann M, et al. (1994) Application of morphine prior to noxious stimulation differentially modulates expression of Fos, Jun and Krox-24 proteins in rat spinal cord neurons. Neuroscience 58: 305-321.
74. Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H (1997) Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice. Pharmacol Biochem Behav 57: 293-299.
75. Wang ZH, Li SJ, Qi Y, Zhao JJ, Liu XY, et al. (2011) HuD regulates the cpg15 expression via the 39-UTR and AU-rich element. Neurochem Res 36: 1027-1036.
76. Zhang R, Zhang Z, Wang L, Wang Y, Gousev A, et al. (2004) Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab 24: 441-448.